Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer
Jayanta Chatterjee(Indian Institute of Science Bangalore), Sadaf Ghaem‐Maghami(Hammersmith Hospital), Lynsey M. Whilding(Hammersmith Hospital), David L. Phelps(The London College), Nor Haslinda Abd Aziz(National University of Malaysia), Kirsty Flower(The London College), Pei Y. Teo(The London College), Wei Dai(Hubei Polytechnic University), Giorgia Trevisan(Barts Health NHS Trust), Andrew J.T. George(Moorfields Eye Hospital NHS Foundation Trust), John Wahba(The London College), Roberto Dina(Imperial College London), Christian J. Maine(Scripps Research Institute)
Cited by 51
Related Papers
N-Methylation of Peptides: A New Perspective in Medicinal Chemistry
|Accounts of Chemical Research|2008|573
<i>N</i>‐Methylation of Peptides and Proteins: An Important Element for Modulating Biological Functions
|Angewandte Chemie International Edition|2012|483
Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues
|Angewandte Chemie International Edition|2008|375
Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses
|The British Journal of Psychiatry|2018|195